You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

G Protein Mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +6 more
  • Miami, Florida
  • +4 more
Dec 2, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Mitochondrial Myopathies Trial in Maastricht (Intra-arterial delivery of autologous MABs)

Recruiting
  • Mitochondrial Myopathies
  • Intra-arterial delivery of autologous MABs
  • Maastricht, Netherlands
    Maastricht University Medical Center
Jul 24, 2023

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023

Protein Metabolism Disorder Trial in Maastricht (20g whey protein drink ingestion, 20g native canola protein drink ingestion,

Recruiting
  • Protein Metabolism Disorder
  • 20g whey protein drink ingestion
  • +3 more
  • Maastricht, Limburg, Netherlands
    Maastricht University Medical Centre+
Sep 21, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

Recruiting
  • Beta-Thalassemia
  • ARMS PCR
  • Assiut, Egypt
    Faculty of Medicine Assiut University
Jan 30, 2023

Intensive Care Unit Acquired Weakness Trial in Spain (Protein dose 1.5 g/kg/day, Protein dose 1.0 g/kg/day)

Recruiting
  • Intensive Care Unit Acquired Weakness
  • Protein dose 1.5 g/kg/day
  • Protein dose 1.0 g/kg/day
  • Badalona, Barcelona, Spain
  • +17 more
Jun 15, 2023

Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Mediterranean diet supplement with 20 g / day of hemp

Completed
  • Obesity
  • +4 more
  • Mediterranean diet supplement with 20 g / day of hemp protein.
  • Seville, Spain
    University of Seville
Nov 8, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Santa Rosa, California
    Providence Medical Foundation
May 2, 2023

NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Telisotuzumab Vedotin
  • +4 more
  • (no location specified)
Oct 17, 2023

Fabry Disease Trial in Taipei

Recruiting
  • Fabry Disease
    • Taipei, Taiwan
      Investigational Site Number :1580001
    Sep 24, 2023

    Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

    Not yet recruiting
    • Solid Tumor
    • +4 more
    • (no location specified)
    Feb 21, 2023

    Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

    Not yet recruiting
    • Solid Tumor, Adult
    • +4 more
    • (no location specified)
    Apr 24, 2023

    Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

    Recruiting
    • Advanced Solid Tumors
    • GEC255 tablets
    • Chengdu, Sichuan, China
      China West Hospital
    Mar 14, 2023

    Healthy Trial in Oxford (10 g NUTRALYS®S85 Plus pea protein, 20 g NUTRALYS®S85 Plus pea protein, 10 g Whey protein concentrate)

    Completed
    • Healthy
    • 10 g NUTRALYS®S85 Plus pea protein
    • +4 more
    • Oxford, United Kingdom
      Oxford Brookes Centre for Nutrition and Health
    Sep 5, 2022

    Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

    Not yet recruiting
    • Slow-Flow Vascular Malformation
    • +17 more
    • Parkville, Victoria, Australia
      The Royal Children's Hospital
    Aug 7, 2023

    Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

    Active, not recruiting
    • Efficacy
    • Oral sotorasib + IV Panitumumab
    • Seoul, Korea, Republic of
      Korea University Anam Hospital
    Aug 14, 2023

    Advance NSCLC Trial (GFH925, Cetuximab)

    Not yet recruiting
    • Advance Non-small Cell Lung Cancer
    • (no location specified)
    Mar 7, 2023

    Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with

    Recruiting
    • Advanced NSCLC
    • Metastatic Lung Cancer
    • Adagrasib in combination with pembrolizumab
    • Pembrolizumab
    • East Syracuse, New York
    • +2 more
    Nov 28, 2022

    Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

    Recruiting
    • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
    • Montpellier, France
    • +7 more
    Dec 19, 2022

    Medium-chain Acyl-CoA Dehydrogenase Deficiency Trial in Pittsburgh (Sodium phenylbutyrate)

    Recruiting
    • Medium-chain Acyl-CoA Dehydrogenase Deficiency
    • Sodium phenylbutyrate
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Oct 4, 2023

    Periodontitis Trial in Catania (Non-surgical periodontal treatment)

    Completed
    • Periodontitis
    • Non-surgical periodontal treatment
    • Catania, Italy
      AOU Policlinico G. Rodolico
    Apr 18, 2023

    Colorectal Cancer, Breast Cancer Trial in Edmonton (Phenylalanine intake)

    Recruiting
    • Colorectal Cancer
    • Breast Cancer
    • Phenylalanine intake
    • Edmonton, Alberta, Canada
      University of Alberta
    Jan 16, 2023